enterovirus 71 vaccine

From Aaushi
Jump to navigation Jump to search

Indications

* common cause of hand, foot, & mouth disease & other illnesses, including herpangina, viral meningitis, especially in the Asia-Pacific region

Dosage

Notes

More general terms

References

  1. Zhu FC et al Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. May 29, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23726161 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61049-1/abstract
  2. 2.0 2.1 2.2 Zhu F et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014 Feb 27; 370:818 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24571754 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1304923
    Li R et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014 Feb 27; 370:829. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24571755 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1303224